Skip to main content

Table 4 All-cause PPPM healthcare costs among Medicaid beneficiaries with HCV and ALD (cases) and matched patients with HCV and no ALD (comparison)

From: The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective

 

Patients with HCV and ALD (Cases)

Patients with HCV and without ALD (Comparison)

Difference

P-value1

N

1193

1193

  

Inpatient

    

Mean (SD)

$2,649 ($4,179)

$337 ($981)

$2,312

< .001

Median

$905

$0

  

IQR

$0-$3,430

$0-$79

  

Outpatient2

    

Mean (SD)

$713 ($824)

$215 ($320)

$498

< .001

Median

$467

$132

  

IQR

$249-$902

$49-$270

  

Pharmacy

    

Mean (SD)

$791 ($1,401)

$818 ($1,312)

-$27

0.032

Median

$385

$462

  

IQR

$126-$895

$132-$1,029

  

Other costs3

    

Mean (SD)

$784 ($1,541)

$360 ($1,265)

$424

< .001

Median

$171

$90

  

IQR

$51-$669

$18-$208

  

Total costs

    

Mean (SD)

$4,937 ($5,236)

$1,730 ($2,309)

$3,207

< .001

Median

$3,146

$1,002

  
  1. Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
  2. Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.
  3. 1Calculated with the Wilcoxon test for comparison of means.
  4. 2Patients may have received multiple outpatient services on the same day, including hospital outpatient, physician, nurse practitioner, physician assistant, clinic, or other outpatient services.
  5. 3 "Other" costs include nursing home, home health, hospice, and other services.
  6. ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us